Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, T-Cell, Cutaneous × trastuzumab biosimilar HLX02 × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 3 Salivary Gland Neoplasms 1 Malignant Solid Neoplasm 1 Lung Neoplasms 1 Inflammatory Breast Neoplasms 1 Esophageal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Brain Neoplasms 1 Anatomic Stage II Breast Cancer AJCC v8 1 Anatomic Stage I Breast Cancer AJCC v8 1 Advanced Breast Carcinoma 1 Adenocarcinoma Of Esophagus 1

Interventions

Biopsy 4 fludarabine 3 Cyclophosphamide 3 romidepsin 2 pembrolizumab 2 mogamulizumab 2 Specimen Handling 2 tazemetostat 1 talimogene laherparepvec 1 ruxolitinib 1 hypericin 1 fludarabine phosphate 1 cc-486 1 belinostat 1 Valganciclovir 1 Urine Specimen Collection 1 Therapeutics 1 TNTCFP protein 1 Spinal Puncture 1 Polymerase Chain Reaction 1 Pharmacogenomic Variants 1 Nivolumab 1 Mycophenolic Acid 1 Mesna 1 Melphalan 1 Magnetic Resonance Spectroscopy 1 Magnetic Resonance Imaging 1 MEDI-570 1 Light 1 Lenalidomide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡